Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.

Academic Article

Abstract

  • INTRODUCTION: Elevated fibroblast growth factor-23 (FGF23) is an established marker of cardiovascular disease. The underlying reason(s) for the rise accompanying cardiovascular health decline are unclear. Prior studies have shown that FGF23 concentrations are associated with markers of inflammation and insulin resistance but they have been limited by a focus on persons with chronic kidney disease (CKD) and lack of race and sex diversity. The objective of this study was to examine the associations of FGF23 and markers of inflammation, insulin resistance, and anthropometrics in a large cohort of community-dwelling adults. METHODS: Associations of FGF23 with markers of inflammation [interleukin-6 (IL-6), IL-10, high sensitivity-CRP (hsCRP)], insulin utilization [resistin, adiponectin, homeostatic model assessment of insulin resistance (HOMA-IR)] and anthropometrics [BMI and waist circumference (WC)] were examined cross-sectionally in a 1,040 participants randomly selected from the Reason for Geographic and Racial Differences in Stroke (REGARDS) Study, a national study of black and white adults ≥45 years. Effect modification by race and CKD status was tested, and stratified models were analyzed accordingly. RESULTS: Median FGF23 concentration was 69.6 RU/ml (IQR: 53.2, 102.7). Higher quartiles of FGF23 were associated with higher mean concentrations of IL-6, IL-10, hsCRP and resistin (Ptrend<0.001 for all). There were no significant differences in HOMA-IR, adiponectin concentrations, BMI, or WC across FGF23 quartiles in the crude analyses. CKD significantly modified the relationships between FGF23 and inflammatory markers, HOMA-IR, BMI and WC (P ≤ 0.01 for all). In linear regression models adjusted for sociodemographic and clinical variables, FGF23 was positively associated with IL-6, hsCRP, IL-10, HOMA-IR, BMI and WC in individuals without CKD, but not among individuals with CKD. Additionally, FGF23 was positively associated with resistin irrespective of CKD status. CONCLUSIONS: Elevated FGF23 concentrations may be considered a biomarker for decline in metabolic function among individuals with normal kidney function.
  • Published In

  • PLoS ONE  Journal
  • Keywords

  • Adult, Aged, Anthropometry, Biomarkers, Female, Fibroblast Growth Factors, Humans, Inflammation, Insulin Resistance, Male, Middle Aged, Multivariate Analysis, Obesity, Renal Insufficiency, Chronic
  • Digital Object Identifier (doi)

    Author List

  • Hanks LJ; Casazza K; Judd SE; Jenny NS; Gutiérrez OM
  • Start Page

  • e0122885
  • Volume

  • 10
  • Issue

  • 3